vs
Indivior Pharmaceuticals, Inc.（INDV）与Nisun International Enterprise Development Group Co., Ltd（NISN）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是Nisun International Enterprise Development Group Co., Ltd的1.9倍（$357.0M vs $192.5M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs 5.4%，领先23.5%），Nisun International Enterprise Development Group Co., Ltd自由现金流更多（$-69.4M vs $-245.0M）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
Nisun国际企业发展集团有限公司为中国各行业中小型企业提供综合供应链管理解决方案、金融科技服务及产业数字化工具，致力于提升供应链运营效率、降低成本，助力客户实现数字化转型。
INDV vs NISN — 直观对比
营收规模更大
INDV
是对方的1.9倍
$192.5M
净利率更高
INDV
高出23.5%
5.4%
自由现金流更多
NISN
多$175.6M
$-245.0M
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $192.5M |
| 净利润 | $103.0M | $10.3M |
| 毛利率 | 82.1% | 9.0% |
| 营业利润率 | 22.7% | — |
| 净利率 | 28.9% | 5.4% |
| 营收同比 | — | 0.0% |
| 净利润同比 | 390.5% | 0.2% |
| 每股收益（稀释后） | $0.79 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVNISN
| Q4 25 | $357.0M | — | ||
| Q3 25 | $314.0M | — | ||
| Q2 25 | $302.0M | $192.5M | ||
| Q1 25 | $266.0M | — | ||
| Q3 24 | $307.0M | — | ||
| Q2 24 | $299.0M | $192.5M |
净利润INDVNISN
| Q4 25 | $103.0M | — | ||
| Q3 25 | $42.0M | — | ||
| Q2 25 | $18.0M | $10.3M | ||
| Q1 25 | $47.0M | — | ||
| Q3 24 | $22.0M | — | ||
| Q2 24 | $-97.0M | $10.3M |
毛利率INDVNISN
| Q4 25 | 82.1% | — | ||
| Q3 25 | 73.2% | — | ||
| Q2 25 | 82.8% | 9.0% | ||
| Q1 25 | 83.1% | — | ||
| Q3 24 | 78.5% | — | ||
| Q2 24 | 73.6% | 9.0% |
营业利润率INDVNISN
| Q4 25 | 22.7% | — | ||
| Q3 25 | 13.7% | — | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | 24.8% | — | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | -39.5% | 6.0% |
净利率INDVNISN
| Q4 25 | 28.9% | — | ||
| Q3 25 | 13.4% | — | ||
| Q2 25 | 6.0% | 5.4% | ||
| Q1 25 | 17.7% | — | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | -32.4% | 5.4% |
每股收益（稀释后）INDVNISN
| Q4 25 | $0.79 | — | ||
| Q3 25 | $0.33 | — | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | $0.38 | — | ||
| Q3 24 | $0.16 | — | ||
| Q2 24 | $-0.72 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $45.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-98.0M | $211.1M |
| 总资产 | $1.2B | $271.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVNISN
| Q4 25 | $195.0M | — | ||
| Q3 25 | $445.0M | — | ||
| Q2 25 | $510.0M | $45.0M | ||
| Q1 25 | $373.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $55.9M |
股东权益INDVNISN
| Q4 25 | $-98.0M | — | ||
| Q3 25 | $-207.0M | — | ||
| Q2 25 | $-257.0M | $211.1M | ||
| Q1 25 | $-285.0M | — | ||
| Q3 24 | $-310.0M | — | ||
| Q2 24 | $-281.0M | $204.5M |
总资产INDVNISN
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.5B | $271.4M | ||
| Q1 25 | $1.4B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $268.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | $-69.3M |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | $-69.4M |
| 自由现金流率自由现金流/营收 | -68.6% | -36.0% |
| 资本支出强度资本支出/营收 | 6.7% | 0.0% |
| 现金转化率经营现金流/净利润 | -2.15× | -6.72× |
| 过去12个月自由现金流最近4个季度 | $-93.0M | — |
8季度趋势，按日历期对齐
经营现金流INDVNISN
| Q4 25 | $-221.0M | — | ||
| Q3 25 | $-39.0M | — | ||
| Q2 25 | $158.0M | $-69.3M | ||
| Q1 25 | $75.0M | — | ||
| Q3 24 | $2.0M | — | ||
| Q2 24 | $88.0M | $-69.3M |
自由现金流INDVNISN
| Q4 25 | $-245.0M | — | ||
| Q3 25 | $-59.0M | — | ||
| Q2 25 | $141.0M | $-69.4M | ||
| Q1 25 | $70.0M | — | ||
| Q3 24 | $-5.0M | — | ||
| Q2 24 | $84.0M | $-69.4M |
自由现金流率INDVNISN
| Q4 25 | -68.6% | — | ||
| Q3 25 | -18.8% | — | ||
| Q2 25 | 46.7% | -36.0% | ||
| Q1 25 | 26.3% | — | ||
| Q3 24 | -1.6% | — | ||
| Q2 24 | 28.1% | -36.0% |
资本支出强度INDVNISN
| Q4 25 | 6.7% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 5.6% | 0.0% | ||
| Q1 25 | 1.9% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 1.3% | 0.0% |
现金转化率INDVNISN
| Q4 25 | -2.15× | — | ||
| Q3 25 | -0.93× | — | ||
| Q2 25 | 8.78× | -6.72× | ||
| Q1 25 | 1.60× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | — | -6.73× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
NISN
| Supply chain trading business | $142.1M | 74% |
| Small and Medium Enterprise financing solutions | $48.5M | 25% |
| Supply Chain financing solutions | $1.9M | 1% |
